Clinical Trial Update: Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis [Phase 4]

View source ↗

Summary

A phase 4 dose-ranging trial to evaluate budesonide rectal foam in pediatric patients aged 5-17 with active distal ulcerative colitis; study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide Rectal Foam (budesonide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 4 | Status: NOT_YET_RECRUITING